GILT Modulates CD4+ T-Cell tolerance to the melanocyte differentiation antigen tyrosinase-related protein 1

Journal of Investigative Dermatology

Volumn 132, Issue 1, 2012, Pages 154-162

  Rausch, Matthew P ^a,b   Hastings, K Taraszka ^a,b  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CYTOKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE LYSOSOMAL THIOL REDUCTASE; INTERLEUKIN 2; LYSOSOME ENZYME; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; T LYMPHOCYTE RECEPTOR; TYROSINASE RELATED PROTEIN 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; AUTOIMMUNITY; CANCER IMMUNOTHERAPY; CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; FLOW CYTOMETRY; IMMUNE SYSTEM; IMMUNOLOGICAL TOLERANCE; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MELANOCYTE; MELANOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN; THYMOCYTE; TRANSGENIC MOUSE; VITILIGO;

EID: 84856083108     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2011.236     Document Type: Article

References (52)

1. Anderson MS, Venanzi ES, Klein L et al. (2002) Projection of an immunological self shadow within the thymus by the aire protein. Science 298:1395-401 (Pubitemid 35346134)
2. Apostolou I, Sarukhan A, Klein L et al. (2002) Origin of regulatory T cells with known specificity for antigen. Nat Immunol 3:756-63
3. Arunachalam B, Phan UT, Geuze HJ et al. (2000) Enzymatic reduction of disulfide bonds in lysosomes: characterization of a gamma-interferoninducible lysosomal thiol reductase (GILT). Proc Natl Acad Sci USA 97:745-50 (Pubitemid 30070380)
4. Berson JF, Harper DC, Tenza D et al. (2001) Pmel17 initiates premelanosome morphogenesis within multivesicular bodies. Mol Biol Cell 12:3451-64 (Pubitemid 33108478)
5. Bruder D, Westendorf AM, Hansen W et al. (2005) On the edge of autoimmunity: T-cell stimulation by steady-state dendritic cells prevents autoimmune diabetes. Diabetes 54:3395-401 (Pubitemid 43334328)
6. Bryant P, Ploegh H (2004) Class II MHC peptide loading by the professionals. Curr Opin Immunol 16:96-102 (Pubitemid 38198123)
7. Cohen JN, Guidi CJ, Tewalt EF et al. (2010) Lymph node-resident lymphatic endothelial cells mediate peripheral tolerance via Aire-independent direct antigen presentation. J Exp Med 207:681-8
8. Fontenot JD, Gavin MA, Rudensky AY (2003) Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 4:330-6 (Pubitemid 36432314)
9. Fusenig NE, Amer SM, Boukamp P et al. (1978) Characteristics of chemically transformed mouse epidermal cells in vitro and in vivo. Bull Cancer 65:271-9 (Pubitemid 9043730)
10. Gallegos AM, Bevan MJ (2004) Central tolerance to tissue-specific antigens mediated by direct and indirect antigen presentation. J Exp Med 200:1039-49 (Pubitemid 39431128)
11. Garcia-Borron JC, Solano F (2002) Molecular anatomy of tyrosinase and its related proteins: beyond the histidine-bound metal catalytic center. Pigment Cell Res 15:162-73 (Pubitemid 34608974)
12. Gardner JM, Devoss JJ, Friedman RS et al. (2008) Deletional tolerance mediated by extrathymic Aire-expressing cells. Science 321:843-7
13. Haque MA, Li P, Jackson SK et al. (2002) Absence of gamma- interferoninducible lysosomal thiol reductase in melanomas disrupts T cell recognition of select immunodominant epitopes. J Exp Med 195:1267-77 (Pubitemid 34564329)
14. Hastings KT, Lackman RL, Cresswell P (2006) Functional requirements for the lysosomal thiol reductase GILT in MHC class II-restricted antigen processing. J Immunol 177:8569-77 (Pubitemid 44893819)
15. Hinterberger M, Aichinger M, da Costa OP et al. (2010) Autonomous role of medullary thymic epithelial cells in central CD4(+) T cell tolerance. Nat Immunol 11:512-9
16. Hogquist KA, Jameson SC, Heath WR et al. (1994) T cell receptor antagonist peptides induce positive selection. Cell 76:17-27 (Pubitemid 24035278)
17. Jordan MS, Boesteanu A, Reed AJ et al. (2001) Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide. Nat Immunol 2:301-6 (Pubitemid 33706340)
18. Kisielow P, Bluthmann H, Staerz UD et al. (1988) Tolerance in T-cell-receptor transgenic mice involves deletion of nonmature CD4+8+ thymocytes. Nature 333:742-6
19. Klein L, Hinterberger M, Wirnsberger G et al. (2009) Antigen presentation in the thymus for positive selection and central tolerance induction. Nat Rev Immunol 9:833-44
20. Kobayashi H, Kokubo T, Sato K et al. (1998) CD4+ T cells from peripheral blood of a melanoma patient recognize peptides derived from nonmutated tyrosinase. Cancer Res 58:296-301 (Pubitemid 28047070)
21. Kretschmer K, Apostolou I, Hawiger D et al. (2005) Inducing and expanding regulatory T cell populations by foreign antigen. Nat Immunol 6: 1219-27 (Pubitemid 43045633)
22. Lang KS, Caroli CC, Muhm A et al. (2001) HLA-A2 restricted, melanocytespecific CD8(+) T lymphocytes detected in vitiligo patients are related to disease activity and are predominantly directed against MelanA/MART1. J Invest Dermatol 116:891-7 (Pubitemid 32554374)
23. Lee JW, Epardaud M, Sun J et al. (2007) Peripheral antigen display by lymph node stroma promotes T cell tolerance to intestinal self. Nat Immunol 8:181-90 (Pubitemid 46152649)
24. Liston A, Lesage S, Wilson J et al. (2003) Aire regulates negative selection of organ-specific T cells. Nat Immunol 4:350-4 (Pubitemid 36432317)
25. Lo WL, Felix NJ, Walters JJ et al. (2009) An endogenous peptide positively selects and augments the activation and survival of peripheral CD4+ T cells. Nat Immunol 10:1155-61
26. Luster AD, Weinshank RL, Feinman R et al. (1988) Molecular and biochemical characterization of a novel gamma-interferon-inducible protein. J Biol Chem 263:12036-43
27. Mamalaki C, Murdjeva M, Tolaini M et al. (1996) Tolerance in TCR/cognate antigen double-transgenic mice mediated by incomplete thymic deletion and peripheral receptor downregulation. Dev Immunol 4:299-315 (Pubitemid 26092831)
28. Mandelcorn-Monson RL, Shear NH, Yau E et al. (2003) Cytotoxic T lymphocyte reactivity to gp100, MelanA/MART-1, and tyrosinase, in HLA-A2-positive vitiligo patients. J Invest Dermatol 121:550-6 (Pubitemid 37072267)
29. Maric M, Arunachalam B, Phan UT et al. (2001) Defective antigen processing in GILT-free mice. Science 294:1361-5 (Pubitemid 33063106)
30. McCaughtry TM, Baldwin TA, Wilken MS et al. (2008) Clonal deletion of thymocytes can occur in the cortex with no involvement of the medulla. J Exp Med 205:2575-84
31. Muranski P, Boni A, Antony PA et al. (2008) Tumor-specific Th17-polarized cells eradicate large established melanoma. Blood 112:362-73
32. Naughton GK, Eisinger M, Bystryn JC (1983) Antibodies to normal human melanocytes in vitiligo. J Exp Med 158:246-51 (Pubitemid 13073526)
33. Negroiu G, Dwek RA, Petrescu SM (2000) Folding and maturation of tyrosinase-related protein-1 are regulated by the post-translational formation of disulfide bonds and by N-glycan processing. J Biol Chem 275:32200-7
34. Nichols LA, Chen Y, Colella TA et al. (2007) Deletional self-tolerance to a melanocyte/melanoma antigen derived from tyrosinase is mediated by a radio-resistant cell in peripheral and mesenteric lymph nodes. J Immunol 179:993-1003
35. Nikolic-Zugic J, Bevan MJ (1990) Role of self-peptides in positively selecting the T-cell repertoire. Nature 344:65-7
36. Ogg GS, Rod Dunbar P, Romero P et al. (1998) High frequency of skinhoming melanocyte-specific cytotoxic T lymphocytes in autoimmune vitiligo. J Exp Med 188:1203-8 (Pubitemid 28443344)
37. Overwijk WW, Lee DS, Surman DR et al. (1999) Vaccination with a recombinant vaccinia virus encoding a "self" antigen induces autoimmune vitiligo and tumor cell destruction in mice: requirement for CD4(+) T lymphocytes. Proc Natl Acad Sci USA 96:2982-7 (Pubitemid 29148830)
38. Palermo B, Campanelli R, Garbelli S et al. (2001) Specific cytotoxic T lymphocyte responses against Melan-A/MART1, tyrosinase and gp100 in vitiligo by the use of major histocompatibility complex/peptide tetramers: the role of cellular immunity in the etiopathogenesis of vitiligo. J Invest Dermatol 117:326-32 (Pubitemid 34205718)
39. Parkhurst MR, Riley JP, Robbins PF et al. (2004) Induction of CD4+ Th1 lymphocytes that recognize known and novel class II MHC restricted epitopes from the melanoma antigen gp100 by stimulation with recombinant protein. J Immunother 27:79-91 (Pubitemid 38282727)
40. Quezada SA, Simpson TR, Peggs KS et al. (2010) Tumor-reactive CD4(+) T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts. J Exp Med 207:637-50
41. Rausch MP, Irvine KR, Antony PA et al. (2010) GILT accelerates autoimmunity to the melanoma antigen tyrosinase-related protein 1. J Immunol 185:2828-35
42. Robbins PF, El-Gamil M, Li YF et al. (2002) Multiple HLA class II-restricted melanocyte differentiation antigens are recognized by tumor-infiltrating lymphocytes from a patient with melanoma. J Immunol 169:6036-47 (Pubitemid 35291712)
43. Sealy R, Chaka W, Surman S et al. (2008) Target peptide sequence within infectious human immunodeficiency virus type 1 does not ensure envelope-specific T-helper cell reactivation: influences of cysteine protease and gamma interferon-induced thiol reductase activities. Clin Vaccine Immunol 15:713-9 (Pubitemid 351967050)
44. Smyth IM, Wilming L, Lee AW et al. (2006) Genomic anatomy of the Tyrp1 (brown) deletion complex. Proc Natl Acad Sci USA 103:3704-9 (Pubitemid 43376619)
45. Swat W, Ignatowicz L, Von Boehmer H et al. (1991) Clonal deletion of immature CD4+8+ thymocytes in suspension culture by extrathymic antigen-presenting cells. Nature 351:150-3 (Pubitemid 21896554)
46. Topalian SL, Gonzales MI, Parkhurst M et al. (1996) Melanoma-specific CD4+ T cells recognize nonmutated HLA-DR-restricted tyrosinase epitopes. J Exp Med 183:1965-71 (Pubitemid 26158888)
47. Touloukian CE, Leitner WW, Robbins PF et al. (2002) Expression of a "self-"antigen by human tumor cells enhances tumor antigen-specific CD4(+) T-cell function. Cancer Res 62:5144-7 (Pubitemid 35024583)
48. Touloukian CE, Leitner WW, Topalian SL et al. (2000) Identification of a MHC class II-restricted human gp100 epitope using DR4-IE transgenic mice. J Immunol 164:3535-42 (Pubitemid 30169805)
49. Van Geel NA, Mollet IG, De Schepper S et al. (2010) First histopathological and immunophenotypic analysis of early dynamic events in a patient with segmental vitiligo associated with halo nevi. Pigment Cell Melanoma Res 23:375-84
50. Wang S, Bartido S, Yang G et al. (1999) A role for a melanosome transport signal in accessing the MHC class II presentation pathway and in eliciting CD4+ T cell responses. J Immunol 163:5820-6
51. Xie Y, Akpinarli A, Maris C et al. (2010) Naive tumor-specific CD4(+) T cells differentiated in vivo eradicate established melanoma. J Exp Med 207:651-67
52. Zal T, Weiss S, Mellor A et al. (1996) Expression of a second receptor rescues self-specific T cells from thymic deletion and allows activation of autoreactive effector function. Proc Natl Acad Sci USA 93:9102-7 (Pubitemid 26282025)